Literature DB >> 20556583

Cloning of WWOX gene and its growth-inhibiting effects on ovarian cancer cells.

Zhoufang Xiong1, Sha Hu, Zehua Wang.   

Abstract

The growth-inhibiting and apoptosis-inducing effects of WW domain-containing oxidoreductase (WWOX) gene on ovarian cancer cell line A2780 were investigated. The full length cDNA of human WWOX gene was amplified from normal human ovary tissues. The correct cDNA of full length WWOX was subcloned into eukaryocytic expression vector pCMV. After introduction of WWOX gene into cancer cells with liposome, the WWOX mRNA and protein level in the cancer cells were detected by reverse transcription polymerase chain reaction (RT-PCR) and immunoblotting. The growth activities of cancer cells were detected by Trypan blue staining. The clone formation assay in soft agar was employed to observe the proliferation of the cancer cells. Apoptosis was examined by DNA ladder and acridine orange-ethidium bromide fluorescent staining. The results showed that 72 h after WWOX gene transfection, the WWOX expression was increased significantly (P<0.01). The growth of ovarian cancer cells was decreased by 16.41% to 38.49% (P<0.01). The clone formation abilities were reduced (P<0.01). Some cancer cells presented the characteristic morphological changes of apoptosis with obvious ladder bands on electrophoresis. The apoptosis rate was (20.7+/-6.0)% (P<0.01). It was concluded that over-expression of WWOX gene could induce apoptosis and inhibit the growth of ovarian cancer cells, which might be potentially useful in the gene therapy of ovarian cancers.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20556583     DOI: 10.1007/s11596-010-0358-z

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  8 in total

Review 1.  A potential role of p53 and WOX1 in mitochondrial apoptosis (review).

Authors:  Nan-Shan Chang
Journal:  Int J Mol Med       Date:  2002-01       Impact factor: 4.101

2.  WWOX, the FRA16D gene, behaves as a suppressor of tumor growth.

Authors:  A K Bednarek; C L Keck-Waggoner; R L Daniel; K J Laflin; P L Bergsagel; K Kiguchi; A J Brenner; C M Aldaz
Journal:  Cancer Res       Date:  2001-11-15       Impact factor: 12.701

Review 3.  Common chromosomal fragile sites and cancer: focus on FRA16D.

Authors:  Louise V O'Keefe; Robert I Richards
Journal:  Cancer Lett       Date:  2005-10-20       Impact factor: 8.679

4.  WWOX: a candidate tumor suppressor gene involved in multiple tumor types.

Authors:  A J Paige; K J Taylor; C Taylor; S G Hillier; S Farrington; D Scott; D J Porteous; J F Smyth; H Gabra; J E Watson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

5.  WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer.

Authors:  A K Bednarek; K J Laflin; R L Daniel; Q Liao; K A Hawkins; C M Aldaz
Journal:  Cancer Res       Date:  2000-04-15       Impact factor: 12.701

6.  WWOX mRNA expression profile in epithelial ovarian cancer supports the role of WWOX variant 1 as a tumour suppressor, although the role of variant 4 remains unclear.

Authors:  C Gourley; A J W Paige; K J Taylor; D Scott; N-J Francis; R Rush; C M Aldaz; J F Smyth; H Gabra
Journal:  Int J Oncol       Date:  2005-06       Impact factor: 5.650

7.  Functional association between Wwox tumor suppressor protein and p73, a p53 homolog.

Authors:  Rami I Aqeilan; Yuri Pekarsky; Juan J Herrero; Alexey Palamarchuk; Jean Letofsky; Teresa Druck; Francesco Trapasso; Shuang-Yin Han; Gerry Melino; Kay Huebner; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-30       Impact factor: 11.205

8.  WWOX protein expression varies among ovarian carcinoma histotypes and correlates with less favorable outcome.

Authors:  María I Nunez; Daniel G Rosen; John H Ludes-Meyers; Martín C Abba; Hyunsuk Kil; Robert Page; Andres J P Klein-Szanto; Andrew K Godwin; Jinsong Liu; Gordon B Mills; C Marcelo Aldaz
Journal:  BMC Cancer       Date:  2005-06-27       Impact factor: 4.430

  8 in total
  9 in total

Review 1.  Alteration of WWOX in human cancer: a clinical view.

Authors:  Izabela Baryła; Ewa Styczeń-Binkowska; Andrzej K Bednarek
Journal:  Exp Biol Med (Maywood)       Date:  2015-02-13

Review 2.  Role of WW domain proteins WWOX in development, prognosis, and treatment response of glioma.

Authors:  Shin-Yi Liu; Ming-Fu Chiang; Yu-Jen Chen
Journal:  Exp Biol Med (Maywood)       Date:  2014-11-27

Review 3.  Gene Therapy for Malignant and Benign Gynaecological Disorders: A Systematic Review of an Emerging Success Story.

Authors:  Ekati Drakopoulou; Nicholas P Anagnou; Kalliopi I Pappa
Journal:  Cancers (Basel)       Date:  2022-06-30       Impact factor: 6.575

4.  Establishment of apoptotic regulatory network for genetic markers of colorectal cancer.

Authors:  Yibin Hao; Guoyong Shan; Kejun Nan
Journal:  Saudi J Biol Sci       Date:  2017-01-26       Impact factor: 4.219

Review 5.  WWOX Tumor Suppressor Gene in Breast Cancer, a Historical Perspective and Future Directions.

Authors:  Karolina Pospiech; Elzbieta Płuciennik; Andrzej K Bednarek
Journal:  Front Oncol       Date:  2018-08-28       Impact factor: 6.244

6.  Diverse effect of WWOX overexpression in HT29 and SW480 colon cancer cell lines.

Authors:  Magdalena Nowakowska; Karolina Pospiech; Urszula Lewandowska; Agnieszka W Piastowska-Ciesielska; Andrzej Kazimierz Bednarek
Journal:  Tumour Biol       Date:  2014-06-19

7.  WWOX modulates the gene expression profile in the T98G glioblastoma cell line rendering its phenotype less malignant.

Authors:  Katarzyna Kośla; Magdalena Nowakowska; Karolina Pospiech; Andrzej K Bednarek
Journal:  Oncol Rep       Date:  2014-07-17       Impact factor: 3.906

8.  Establishment of optimal regulatory network of colorectal cancer based on p42.3 protein.

Authors:  Yibin Hao; Jianhua Zhang; Guoyong Shan; Ning Zhang; Wenwen Jin; Kejun Nan
Journal:  Saudi J Biol Sci       Date:  2017-11-09       Impact factor: 4.219

Review 9.  Recent Progress in Gene Therapy for Ovarian Cancer.

Authors:  Ángela Áyen; Yaiza Jiménez Martínez; Juan A Marchal; Houria Boulaiz
Journal:  Int J Mol Sci       Date:  2018-06-30       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.